California Public Employees Retirement System Red Hill Biopharma Ltd. Transaction History

California Public Employees Retirement System

  • $141 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$5.98 - $7.51 $263,120 - $330,440
-44,000 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$6.98 - $11.29 $31,291 - $50,613
-4,483 Reduced 9.25%
44,000 $322,000
Q4 2020

Feb 02, 2021
BUY
$7.81 - $10.39 $27,983 - $37,227
3,583 Added 7.98%
48,483 $392,000
Q3 2020

Nov 05, 2020
BUY
$6.34 - $10.83 $7,608 - $12,996
1,200 Added 2.75%
44,900 $459,000
Q2 2020

Aug 12, 2020
BUY
$4.6 - $8.6 $201,019 - $375,820
43,700 New
43,700 $293,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email